在比利时的初级保健中,稳定的慢性肺炎患者的高血红蛋白细胞计数:流行率和临床特征
Inès Van Rossem1, Sander Deridder2, Aline Beckwée1
1Department of Family Medicine and Chronic Care, Vrije Universiteit Brussel, Brussels, Belgium.
Acta clinica Belgica
|June 14, 2025
概括
乙酸性慢性阻塞性肺病 (COPD) 在比利时的初级保健中很普遍,许多患者表现出血中乙酸细胞计数 (BEC) 的升高. 维护性吸入性皮质类固醇 (ICS) 的使用也很常见,这表明需要个性化的COPD管理.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 异性慢性阻塞性肺病 (COPD) 是一个公认的表型.
- 血中乙氨基酸细胞数量升高 (BECs) 表明对吸入性皮质类固醇 (ICS) 的反应更好.
- 了解BEC分布和ICS在初级保健中的使用对于治疗策略至关重要.
研究的目的:
- 描述比利时初级保健中稳定的COPD患者中BEC的分布.
- 评估这个人群中维护ICS使用的流行率.
- 根据BEC值来比较临床特征.
主要方法:
- 两家比利时初级保健机构的电子健康记录的回顾性分析.
- 基于BEC GOLD值 (100和300细胞/μL) 的患者二体化.
- 群体之间的人口和临床特征的比较.
主要成果:
- 包括80名稳定的COPD患者; 46%使用维护ICS.
- 中位数BEC为182个细胞/μL,其中71%>100细胞/μL和23%≥300细胞/μL.
- 除了年龄之外,BEC组之间没有发现显著的特征差异.
结论:
- 在比利时的初级保健COPD患者中,升高的BEC和ICS使用是常见的.
- 临床特征在基于乙氨基酸的组之间是相似的,除了年龄.
- 这些发现支持eosinophilic表型在COPD管理中的临床相关性.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
190
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
190
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


